To Study the Correlation of Clinical Severity and Cytokine Storm in COVID-19 Pulmonary Embolism Patients by Using Computed Tomography Pulmonary Angiography (CTPA) Qanadli Clot Burden Scoring System
Authors:
Open Access
- 20 May 2023
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 15 (5) , e39263
Abstract
Background: Pulmonary embolism (PE) is a fatal form of venous thromboembolism (VTE), with an overall untreated mortality of up to 30%. Greater than 50% of patients with lower extremity proximal DVT have concurrent PE at presentation. VTE has been seen in up to one-third of patients with COVID-19 infections requiring intensive care unit (ICU) admission. The objective of this study is to determine the correlation between CT pulmonary angiography, pulmonary embolism clot burden, and the Qanadli scoring system with clinically severe COVID-19 pneumonia and cytokine storm. Material and Method: 153 COVID-19 hospitalized patients who underwent CT pulmonary angiography (CTPA) for likely PE on pretest probability modified Wells criteria were enrolled. COVID-19 pneumonia was classified as URTI (upper respiratory tract infection), mild, severe, and critical COVID pneumonia. For data analysis, we categorized into two groups: (1) the non-severe group included URTI and mild pneumonia, and (2) the severe group included severe and critical pneumonia. We used the Qanadli scoring system to assess the PE percentages of pulmonary vascular obstruction using CTPA. Results: 41.8% (64) of COVID-19 patients were diagnosed with pulmonary embolism (PE) on CTPA. The majority of 51.6% of pulmonary vascular occlusions using the Qanadli scoring system for pulmonary embolism were at segmental arterial levels. Out of 104 COVID-19 cytokine storm patients, 45 (43%) were associated with pulmonary embolism. Overall, a 25% (16) mortality rate was observed in COVID-19 patients with pulmonary embolism. Discussion: The pathogenesis of hypercoagulability in COVID-19 may include direct endothelial cell invasion by the virus, microvascular inflammation, endothelial exocytosis, and endotheliitis. A meta-analysis of 71 studies to investigate the occurrence of PE on CTPA in COVID-19 patients found 48.6% in ICU settings and 65.3% of patients have clots in the peripheral pulmonary vasculature. Conclusions: There is a significant correlation between pulmonary embolism and high clot burden Qanadli CTPA scores, as well as between the severity of COVID-19 pneumonia and mortality. The association between critically ill COVID-19 pneumonia and pulmonary embolism may result in higher mortality and a poor prognostic marker.Keywords
This publication has 29 references indexed in Scilit:
- Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging techniqueHaematologica, 2012
- Long-Term Survival in a Large Cohort of Patients with Venous Thrombosis: Incidence and PredictorsPLOS Medicine, 2012
- Guidelines for the diagnosis and management of disseminated intravascular coagulationBritish Journal of Haematology, 2009
- Clinical Characteristics of Patients with Acute Pulmonary Embolism: Data from PIOPED IIThe American Journal of Medicine, 2007
- Saddle pulmonary embolism diagnosed by CT angiography: Frequency, clinical features and outcomeRespiratory Medicine, 2007
- Incidence and mortality of venous thrombosis: a population‐based studyJournal of Thrombosis and Haemostasis, 2007
- Venous thromboembolismBMJ, 2006
- Natural history of pulmonary embolismProgress in Cardiovascular Diseases, 1975
- Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremitiesThe American Journal of Surgery, 1972
- Deep venous thrombosis and pulmonary embolismThe American Journal of Cardiology, 1959